VEGFA and neoplasm: Interestingly, bevacizumab treatment increased VEGF-C expression (Michaelsen et al., 2018), and up-regulation of VEGF-C has been observed in tumor cells that have acquired resistance to anti-VEGF-A therapy (Wang and Tsai, 2015), suggesting that VEGF-C may compensate for VEGF-A depletion.